TETERBORO, N.J., Sept. 28 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, has been honored as one of the nation's Top 100
Innovators in the prestigious InformationWeek 500 ranking, published in the
September 20 edition of CMP Media's InformationWeek magazine. Quest
Diagnostics ranked #87, up from #149 in 2003.
"We are pleased to be one of InformationWeek's top innovators and to be
included in the InformationWeek 500 for the seventh consecutive year," said
Surya N. Mohapatra, President and Chief Executive Officer. "Quest Diagnostics
is a recognized leader in developing information technology solutions that
provide physicians and patients online access to needed healthcare
information."
Quest Diagnostics, together with its wholly-owned subsidiary, MedPlus, is
a leading developer and integrator of clinical connectivity and data
management solutions for healthcare organizations and clinicians. These
solutions efficiently and securely collect, store, manage and retrieve
clinical information, including laboratory test results, within an
organization, enterprise or community via virtual private networks and/or the
Internet. MedPlus solutions, including eMaxx(R) (physician-focused clinical
integration portal solution) and ChartMaxx(R) (electronic patient record
solution) have been implemented in more than 300 healthcare facilities
throughout North America.
The InformationWeek 500 ranks the nation's most innovative IT users using
a proprietary weighting system that takes into account each company's
management priorities, technology strategies, staffing initiatives and budget
plans. Additional information about the listing is available on the Internet
at: http://www.informationweek.com.
About Quest Diagnostics
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
healthcare professionals to make decisions that improve health. The company
offers the broadest access to diagnostic testing services through its national
network of laboratories and patient service centers, and provides interpretive
consultation through its extensive medical and scientific staff. Quest
Diagnostics is the leading provider of esoteric testing, including gene-based
medical testing, and provides advanced information technology solutions to
improve patient care. Additional company information is available at:
http://www.questdiagnostics.com
Statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, competitive environment, changes in
government regulations, changing relationships with customers, payers,
suppliers and strategic partners and other factors described in the Quest
Diagnostics Incorporated 2003 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
-0- 09/28/2004
/CONTACT: Quest Diagnostics - Laure Park (Investors), +1-201-393-5030, or
Gary Samuels (Media), +1-201-393-5700/
/Web site: http://www.questdiagnostics.com /
(DGX)